COMMUNIQUÉS West-GlobeNewswire

Outlook Therapeutics Expands European Footprint with Exclusive Commercial Distribution Agreement with Mediconsult AG for LYTENAVA™ (bevacizumab gamma) in Switzerland
19/02/2026
Veteran ophthalmology leader with 35+ years of market expertise selected as exclusive Switzerland partner Mediconsult to seek Marketing Authorization and lead commercialization activities for LYTENAVA™ (bevacizumab [...]
Klothea Bio Announces the Launch of a Phase 1b Clinical Trial of AKL003, an Alpha Klotho mRNA Therapeutic, for the Extension of Human Lifespan
19/02/2026
MIAMI, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Klothea Bio, Inc. (“Klothea Bio”), a clinical-stage biotechnology company developing therapeutics based on their proprietary serum klotho platform, today announced the launch of [...]
Cynet Releases 2H 2025 CyOps ECHO Report: AI-Driven Attacks and “Cyber Cartels" Collapse Exploitation Window to Hours
19/02/2026
Frontline incident responders document how adversaries are shifting from breaking security controls to abusing them as designed BOSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cynet , the unified, AI-powered cybersecurity [...]
Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
19/02/2026
Omada for Cholesterol closes a critical gap in cardiovascular care, delivering between-visit support for the many adults whose LDL remains uncontrolled under usual care¹ SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- [...]
Burcon Chiropractic Launches Meniere’s Disease Treatment Clinical Trial in Grand Rapids
19/02/2026
Trial #MDTCT2026 Now Enrolling 50 Participants Diagnosed with Unilateral Meniere’s Disease Grand Rapids, Michigan, U.S.A., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Burcon Chiropractic Announces Clinical Trial for Meniere’s [...]
Aaptiv Launches New MSK App in Partnership With movr
19/02/2026
Movement Health Solution Provides Clinical-Grade Care for Musculoskeletal Pain and Recovery CARLSBAD, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Aaptiv, a leading fitness and wellness platform for employers, today [...]
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
19/02/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced Chief Executive Officer Michael Castagna, PharmD is scheduled to present and share [...]
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
19/02/2026
SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
19/02/2026
Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry SALT LAKE CITY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic [...]
Mapi Pharma to Host Virtual KOL Event to Discuss Glatiramer Acetate Once a Month Depot for Primary Progressive Multiple Sclerosis, on March 3, 2026
19/02/2026
NESS ZIONA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable [...]
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
19/02/2026
Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study preparations Espoo, Finland, 19 February 2026: Herantis Pharma Plc (“Herantis”), a [...]
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
19/02/2026
CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today highlighted the intrinsic value of its [...]
Family Insight Appoints Kyle Williamson as Vice President of Business Development, Accelerates Expansion and Partnerships in Value-Based Care
19/02/2026
RICHMOND, Va., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Family Insight, PC , a Whitecap Care, LLC company and a leader in value-based care (VBC) and behavioral health, announces the appointment of Kyle Williamson as vice [...]
Human Appeal reaches over 862,000 people with food, water and life-saving emergency response amid ongoing Sudan conflict
19/02/2026
The humanitarian charity has made efforts to provide food parcels, hot school meals and assist with clean water supply across Sudan during the ongoing conflict which is driving mass displacement MISSION VIEJO, Calif., [...]
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
19/02/2026
Company Ready to Scale Growth through OneTest™ AI-Powered Blood Tests for Cancer and Longevity GAITHERSBURG, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market leader in cutting- [...]
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
19/02/2026
THE WOODLANDS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
19/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology”; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat [...]
Protara Therapeutics to Participate in Upcoming Investor Conferences
19/02/2026
NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
19/02/2026
HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has entered into agreements with certain holders of its existing warrants for the [...]

Pages